Bacterial antimicrobial resistance (AMR) contributed to 4.95 million deaths worldwide in 2019, making it one of the top global public health and development threats today according to the World Health Organisation.
At the ground-breaking Antimicrobial Stewardship Center of Excellence Symposium held in Kula Lumpur on 22 November, IHH Malaysia and our Premier Integrated Labs joined forces with bioMérieux, to drive industry collaboration in tackling AMR.
The symposium highlighted the importance of diagnostics in AMR control, the link between AMR and judicious use of antibiotics, and initiatives in the public and private healthcare sector for controlling AMR.
Jean-François Naa, CEO of IHH Healthcare Malaysia, expressed his commitment, stating, "At IHH Healthcare Malaysia, combating AMR is ingrained in our global sustainability goals. Our active AMS committee strategically spearheads initiatives. In this battle, knowledge is our strongest ally. The exchange of insights between global experts, local healthcare leaders, and private providers is crucial as we navigate uncharted waters. Moving forward, strategic collaboration is paramount to combat resistance instead of working in silos."
Related Stories
Agilus Diagnostics Expands Access to Next-Generation Precision Genomics
Agilus Diagnostics, a subsidiary of Fortis Healthcare, has installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory, marking a major step forward for precision genomics in India.
Parkway Shanghai Opens International Centre for Hepatobiliary and Pancreatic Diseases
Mount Elizabeth Hospitals Celebrate 97 Wins at Singapore Health Quality Service Awards 2026
Celebrating the People of Gleneagles Hong Kong
Acibadem Powers Africa’s Premier Football Tournament
Gleneagles JPMC Supports the Children Cancer Foundation
Extending its corporate giving efforts, Gleneagles JPMC presented a cash donation of BND10,000 during its visit to the Yayasan Kanser Kanak-Kanak (YASKA).
